Related Experiment Videos
The emerging p53 gene family
1Howard Hughes Medical Institute and Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA. william_kaelin@dfci.harvard.edu
Journal of the National Cancer Institute
|April 15, 1999
Summary
The p53 protein family, including p73 and p51, plays a role in tumor suppression. Unlike p53, p73 and p51 are not frequently mutated in cancers and have distinct regulatory mechanisms.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- p53 protein is crucial for tumor suppression by regulating cell cycle and apoptosis.
- Two related proteins, p73 and p51 (also known as p40, p63, KET, or p73L), share homology with p53.
- These family members can activate p53-responsive promoters and induce apoptosis when overproduced.
Purpose of the Study:
- To explore the differences between p53, p73, and p51.
- To investigate the potential roles of p73 and p51 in cell growth control and carcinogenesis.
- To understand the unique characteristics of p73 and p51 compared to p53.
Main Methods:
- Comparative analysis of protein function and regulation.
- Examination of gene activation and apoptosis induction.
- Review of mutation frequencies in human cancers.
- Investigation of protein isoform production and tissue-specific expression.
Main Results:
- p73 is not induced by DNA damage and evades inactivation by viral oncoproteins.
- p73 and p51 do not appear to be frequently mutated in human cancers.
- Cells produce multiple isoforms of p73 and p51 through alternative splicing.
- p73 and p51 expression is restricted to certain tissues.
Conclusions:
- p73 and p51 exhibit distinct properties compared to p53, particularly in their regulation and mutation status.
- The differential expression and isoform production suggest specialized roles for p73 and p51.
- Further research is needed to fully elucidate the functions of p73 and p51 in cancer development and prevention.